B2B Revenue Growth Platform Novel Capital Announces Seed Extension Funding
18 juil. 2022 10h30 HE
|
Novel Capital
KANSAS CITY, Mo., July 18, 2022 (GLOBE NEWSWIRE) -- Novel Capital, the fintech Revenue Growth Platform that helps B2B businesses accelerate their growth, today announced a seed extension round led...
Novel Capital Teams Up With GrowthX to Launch the Novel Sales Bootcamp
28 juin 2022 09h00 HE
|
Novel Capital
KANSAS CITY, Mo., June 28, 2022 (GLOBE NEWSWIRE) -- Novel Capital, the fintech Revenue Growth Platform that helps B2B businesses accelerate their growth, is providing a 16-week Novel Sales Bootcamp...
Revenue-Based Financing Platform, Novel Capital, Announces $115M in Funding to Transform How Companies with Predictable Revenue Fund Their Growth
17 mars 2022 10h00 HE
|
Novel Capital
KANSAS CITY, Mo., March 17, 2022 (GLOBE NEWSWIRE) -- Novel Capital, a fintech company helping businesses accelerate growth, came out of stealth today with $115M in initial equity and debt funding....
Boldare Launches CTO as a Service with Unique Differentiators that Accelerate Growth and Enrich User Experience
01 déc. 2021 09h00 HE
|
Boldare
CTO as a Service at Boldare Includes a Three-Domain Approach, is Built on the Company’s Holacratic Organizational Structure and Is Delivered More Cost Effectively than Competitive Solutions GLIWICE,...
DATA443 CONTINUES TO ACCELERATE GROWTH WITH NEW OFFICE IN DUBAI, SIGNS AGREEMENT WITH CATEGORY LEADING MASTER DISTRIBUTOR
07 déc. 2020 11h06 HE
|
Data443 Risk Mitigation, Inc.
Leverages Recent Client Wins, Capturing Significant Territory Coverage RESEARCH TRIANGLE PARK, NC, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Data443 Risk Mitigation, Inc. (OTCPK: ATDS), the leading data...
LiveWire Ergogenics Further Develops Foundation to Accelerate Growth Prior to Recreational Marijuana Laws Taking Effect
13 déc. 2017 08h30 HE
|
LiveWire Ergogenics, Inc
Anaheim, CA, Dec. 13, 2017 (GLOBE NEWSWIRE) -- LiveWire Ergogenics, Inc. (OTC: LVVV), a company focused on research partnerships, product development and commercialization of cannabinoid-based...